A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase
D. McCafferty (Belfast, United Kingdom), K. Moffitt (Belfast, United Kingdom), C. Robb (Belfast, United Kingdom), D. Ramsay (Belfast, United Kingdom), A. Kennedy (Belfast, United Kingdom), T. Ferguson (Belfast, United Kingdom), B. Walker (Belfast, United Kingdom)
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Session: Clinical and functional monitoring in airway disease
Session type: Thematic Poster
Number: 4450
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. McCafferty (Belfast, United Kingdom), K. Moffitt (Belfast, United Kingdom), C. Robb (Belfast, United Kingdom), D. Ramsay (Belfast, United Kingdom), A. Kennedy (Belfast, United Kingdom), T. Ferguson (Belfast, United Kingdom), B. Walker (Belfast, United Kingdom). A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase. 4450
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020
Investigating optimal sputum processing methods for active neutrophil elastase quantification Source: International Congress 2017 – Techniques in biomarker selection Year: 2017
An innovative high sensitivity tool for active neutrophil elastase quantification Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
A rapid method to increase the clinical use of sputum inflammatory cells Source: International Congress 2017 – Techniques in biomarker selection Year: 2017
A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019 Year: 2019
IP-10 measurement using a point of care test for the diagnosis of active tuberculosis Source: Annual Congress 2011 - What is new in tuberculosis immunodiagnosis? Year: 2011
A study to assess the magnitude and reasons of initial default among sputum smear positive pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis control Year: 2010
Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Comparison of different sputum examination methods to determine time for discontinuation of respiratory isolation for tuberculosis patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
Comparative study on the diagnostic value of a modern gamma-interferon test applied in blood and bronchoalveolar lavage in children suspected of tuberculosis - final results Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020
Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001
The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019 Year: 2020
Sputum induction in asthmatic children: safety in children and feasibility of new methods of monitoring inflammation in sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006
A comparison of sputum induction methods Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Comparison of the diagnostic value of immunological test, applied to two types of biological fluids - venous blood and bronchoalveolar lavage in children with tuberculosis Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018
What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)? Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003